Wyeth/Progenics File Methylnaltrexone Injection NDA For Opioid-Induced Constipation
This article was originally published in The Pink Sheet Daily
Executive Summary
Companies will meet with FDA in May to discuss new study for an oral formulation, Wyeth tells “The Pink Sheet” DAILY.